Anticoagulation in Older Adults - Lown Right Care: Reducing Overuse and Underuse - ...
Jun 15, 2020 - A collaboration between AFP and the Lown Institute promotes a vision of delivering health care that is based on the evidence, balanced in its approach, and focused on the patient.
American Family Physician : Lown Right Care: Reducing Overuse and Underuse
https://www.aafp.org/afp/2020/0615/p748.html
Anticoagulation: Updated Guidelines for Outpatient Management - American Family Physician
Oct 1, 2019 - Anticoagulation therapy is recommended for preventing, treating, and reducing the recurrence of venous thromboembolism, and preventing stroke in persons with atrial fibrillation. Direct oral anticoagulants are first-line agents for eligible patients for treating venous thromboembolism ...
American Family Physician : Article
https://www.aafp.org/afp/2019/1001/p426.html
Effectiveness and Safety of Factor Xa Inhibitors in Patients with Atrial Fibrillation -...
Oct 1, 2019 - Treatment of AFib with a factor Xa inhibitor results in a decrease in the combined end point of stroke and embolic events (odds ratio [OR] = 0.89; 95% CI, 0.82 to 0.97), as well as a decrease in intracranial hemorrhage (OR = 0.50; 95% CI, 0.42 to 0.59) and all-cause mortality (OR = ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/1001/p405.html
Bridging Warfarin Before Colonoscopy in Patients with Atrial Fibrillation - FPIN's ...
Apr 15, 2019 - A limited number of trials that examined the risk of temporary interruption of anticoagulation before a variety of procedures did not find a reduction in the risk of stroke, but they did show an increased risk of bleeding events and venous thromboembolism (VTE) in patients who were ...
American Family Physician : FPIN's Clinical Inquiries
https://www.aafp.org/afp/2019/0415/p519.html
Evaluating Benefits and Harms of Anticoagulation in Patients with Atrial Fibrillation -...
Dec 15, 2018 - In patients with NVAF, anticoagulants decrease the risk of stroke by approximately 60%. However, they also significantly increase the risk of a major bleeding event or intracranial hemorrhage.
American Family Physician : Point-of-Care Guides
https://www.aafp.org/afp/2018/1215/p751.html
Edoxaban (Savaysa) for the Prevention of Thromboembolic Events - STEPS - American ...
Apr 15, 2018 - Edoxaban is an alternative to warfarin and other oral anticoagulants for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of deep venous thrombosis and pulmonary embolism.
American Family Physician : STEPS
https://www.aafp.org/afp/2018/0415/p529.html
New Anticoagulants vs. Warfarin in Atrial Fibrillation: No Clear Winner - POEMs - ...
Jul 15, 2014 - In this meta-analysis, newer anticoagulants appear to be slightly more effective than warfarin in the short term (two years) in preventing strokes of all kinds in patients with atrial fibrillation. However, they are no more effective than warfarin in preventing ischemic strokes, and ...
American Family Physician : POEMs
https://www.aafp.org/afp/2014/0715/p110a.html
Oral Anticoagulants vs. Antiplatelet Therapy - Cochrane for Clinicians - American ...
May 1, 2008 - Compared with antiplatelet therapy, oral anticoagulation significantly reduces stroke at an average follow-up of one to three years, but does not reduce mortality. Intracranial or extracranial hemorrhage is more common with anticoagulation and must be weighed against its therapeutic ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2008/0501/p1250.html
navigate_before 1 navigate_next